Expert opinion on biological therapyHumansPsoriasisRetrospective StudiesFemaleMale
Real-world effectiveness and predictors of complete skin clearance (PASI 100) with anti-IL-23 monoclonal antibodies in moderate-to-severe psoriasis: a retrospective cohort study.
Alessandra Michelucci, Giorgia Salvia, Nicolò Mori, Simone Sturli, Flavia Manzo Margiotta, Salvatore Panduri, Riccardo Morganti, Marco Romanelli, Valentina Dini
Published: 202510.1080/14712598.2025.2584387
Abstract
BACKGROUND: Anti-IL-23 monoclonal antibodies have shown strong efficacy in achieving complete clearance (PASI 100) in psoriasis. Real-world evidence is needed to confirm these outcomes and define predictors of response. RESEARCH DESIGN AND METHODS: W…
Preview only. Read the full abstract at the source